Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

DNA Repair and Cancer Therapy: Targeting APE1/Ref-1 Using Dietary Agents.

Raffoul JJ, Heydari AR, Hillman GG.

J Oncol. 2012;2012:370481. Epub 2012 Sep 10.

2.

The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.

Fishel ML, Kelley MR.

Mol Aspects Med. 2007 Jun-Aug;28(3-4):375-95. Epub 2007 May 3. Review.

PMID:
17560642
3.

Soy isoflavones augment radiation effect by inhibiting APE1/Ref-1 DNA repair activity in non-small cell lung cancer.

Singh-Gupta V, Joiner MC, Runyan L, Yunker CK, Sarkar FH, Miller S, Gadgeel SM, Konski AA, Hillman GG.

J Thorac Oncol. 2011 Apr;6(4):688-98. doi: 10.1097/JTO.0b013e31821034ae.

4.

Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.

Raffoul JJ, Banerjee S, Singh-Gupta V, Knoll ZE, Fite A, Zhang H, Abrams J, Sarkar FH, Hillman GG.

Cancer Res. 2007 Mar 1;67(5):2141-9.

5.

Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.

Kelley MR, Cheng L, Foster R, Tritt R, Jiang J, Broshears J, Koch M.

Clin Cancer Res. 2001 Apr;7(4):824-30.

6.

Soy isoflavones sensitize cancer cells to radiotherapy.

Hillman GG, Singh-Gupta V.

Free Radic Biol Med. 2011 Jul 15;51(2):289-98. doi: 10.1016/j.freeradbiomed.2011.04.039. Epub 2011 May 4. Review.

PMID:
21605661
7.

DNA repair-redox enzyme apurinic endonuclease in cervical cancer: evaluation of redox control of HIF-1alpha and prognostic significance.

Schindl M, Oberhuber G, Pichlbauer EG, Obermair A, Birner P, Kelley MR.

Int J Oncol. 2001 Oct;19(4):799-802.

PMID:
11562758
8.

Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation.

Robertson KA, Bullock HA, Xu Y, Tritt R, Zimmerman E, Ulbright TM, Foster RS, Einhorn LH, Kelley MR.

Cancer Res. 2001 Mar 1;61(5):2220-5.

9.

A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity.

Ando K, Hirao S, Kabe Y, Ogura Y, Sato I, Yamaguchi Y, Wada T, Handa H.

Nucleic Acids Res. 2008 Aug;36(13):4327-36. doi: 10.1093/nar/gkn416. Epub 2008 Jun 27.

11.

Going APE over ref-1.

Evans AR, Limp-Foster M, Kelley MR.

Mutat Res. 2000 Oct 16;461(2):83-108. Review.

PMID:
11018583
12.

Daidzein effect on hormone refractory prostate cancer in vitro and in vivo compared to genistein and soy extract: potentiation of radiotherapy.

Singh-Gupta V, Zhang H, Yunker CK, Ahmad Z, Zwier D, Sarkar FH, Hillman GG.

Pharm Res. 2010 Jun;27(6):1115-27. doi: 10.1007/s11095-010-0107-9. Epub 2010 Mar 23.

PMID:
20309614
13.

Small-molecule inhibitors of APE1 DNA repair function: an overview.

Al-Safi RI, Odde S, Shabaik Y, Neamati N.

Curr Mol Pharmacol. 2012 Jan;5(1):14-35. Review.

PMID:
22122462
14.

Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility.

Lu J, Zhang S, Chen D, Wang H, Wu W, Wang X, Lei Y, Wang J, Qian J, Fan W, Hu Z, Jin L, Shen H, Huang W, Wei Q, Lu D.

FASEB J. 2009 Oct;23(10):3459-69. doi: 10.1096/fj.09-136549. Epub 2009 Jun 18.

PMID:
19541747
15.
16.

Tat-APE1/ref-1 protein inhibits TNF-alpha-induced endothelial cell activation.

Song YJ, Lee JY, Joo HK, Kim HS, Lee SK, Lee KH, Cho CH, Park JB, Jeon BH.

Biochem Biophys Res Commun. 2008 Mar 28;368(1):68-73. doi: 10.1016/j.bbrc.2008.01.037. Epub 2008 Jan 17.

PMID:
18206643
17.

Proteomic study of amyloid beta (25-35) peptide exposure to neuronal cells: Impact on APE1/Ref-1's protein-protein interaction.

Mantha AK, Dhiman M, Taglialatela G, Perez-Polo RJ, Mitra S.

J Neurosci Res. 2012 Jun;90(6):1230-9. doi: 10.1002/jnr.23018. Epub 2012 Feb 20.

PMID:
22488727
18.

Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic.

Shah F, Logsdon D, Messmann RA, Fehrenbacher JC, Fishel ML, Kelley MR.

NPJ Precis Oncol. 2017;1. pii: 19. doi: 10.1038/s41698-017-0023-0. Epub 2017 Jun 8.

19.

Radiosensitization of prostate cancer by soy isoflavones.

Raffoul JJ, Sarkar FH, Hillman GG.

Curr Cancer Drug Targets. 2007 Dec;7(8):759-65. Review.

PMID:
18220535

Supplemental Content

Support Center